Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,794 signal articles · 261 in last 24h · 118,174 total before filter · latest 9m ago
261last 24h
1585last 7d
250● bullish (7d)
161● bearish (7d)
205publishers
AllMacro307Earnings644M&A93Regulatory28Product13Analyst24
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How Oscar Health’s 2026 Profit Turnaround And Guidance Upgrade At Oscar Health (OSCR) Has Changed Its Investment Story
Simply Wall St.12d agobullish
How Oscar Health’s 2026 Profit Turnaround And Guidance Upgrade At Oscar Health (OSCR) Has Changed Its Investment Story

Oscar Health reported second-quarter 2026 results showing a shift from a prior-year loss to net income of US$361.81 million and lifted its full-year 2026 guidance to total revenue of US$18.70–US$19.00 billion and earnings from operations of US$500–US$700 million. This combination of a profit turnaround and a sizeable upgrade to operating earnings expectations suggests Oscar’s underlying operations are running more efficiently than previously anticipated. We’ll now examine how Oscar’s...

Chevron (CVX) Earnings Surge Keeps Its Valuation Story In Focus
Simply Wall St.12d agobullish
Chevron (CVX) Earnings Surge Keeps Its Valuation Story In Focus

Chevron (CVX) has moved into the spotlight after reporting its highest quarterly earnings in six years, with profits tied to Middle Eastern supply disruptions and fresh criticism over windfall gains and elevated fuel prices. See our latest analysis for Chevron. Chevron’s share price has eased in the very short term, with a 1-day share price return of 2.10% and a 7-day share price return of 2.84%. Recent momentum remains positive given a 30-day share price return of 10.89%, a year to date...

Datadog Q2 Earnings Call Highlights
MarketBeat12d agoneutral
Datadog Q2 Earnings Call Highlights

Datadog (NASDAQ:DDOG) reported second-quarter revenue of $1.12 billion, up 36% from a year earlier and above the high end of its guidance range, as growth accelerated across both AI-focused and non-AI customers. Co-founder and Chief Executive Officer Olivier Pomel said revenue growth among non-AI c

Exec Edge12d agobullish
Corpay’s Price Target Raised by Brokers After Earnings Beat

By Jarrett Banks Corpay (NYSE: CPAY) delivered another strong quarter of double-digit organic revenue growth. But increasingly, investors are keyed into management’s capital allocation strategy as a top reason to own the stock. Several analyst notes pointed out that Corpay is evolving into one of the payments industry’s premier capital compounders. JPMorgan said investors should […] The post Corpay’s Price Target Raised by Brokers After Earnings Beat appeared first on ExecEdge.